Yes towie - gumbles said much the same thing. I don't delve as deep as he does into each of the individual project cash flow streams - he has done and shared some good work there.
Welcome back in. I am not expecting a bolter here by any means - 30% - 40% a year compounding I believe is quite acheivable with the chance of substantial upside surprise (see my estimates posted last night) if the organic growth continues at these rates and acquisitionas add to the pie.
- Forums
- ASX - By Stock
- TOX
- fin review
fin review, page-5
Featured News
Add TOX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online